Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCND3 | P30281 | 19/20 | 0.35 |
| ▸ | CDK6 | Q00534 | 19/20 | 0.35 |
| ▸ | CDK4 | P11802 | 18/20 | 0.35 |
| ▸ | CCND1 | P24385 | 18/20 | 0.35 |
| ▸ | TNF | P01375 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24619105 | 0.81 | CCND3 (0.36) | CCND3CDK6CDK4CCND1TNF | |
| SCHEMBL31255091 | 0.77 | CCND3 (0.34) | CCND3CDK6CDK4CCND1TNF | |
| SCHEMBL31413736 | 0.76 | CCND3 (0.36) | CCND3CDK6CDK4CCND1TNF | |
| SCHEMBL30758216 | 0.75 | TNF (0.39) | CCND3CDK6CDK4CCND1TNF | |
| SCHEMBL31373118 | 0.74 | TNF (0.35) | CCND3CDK6CDK4CCND1TNF | |
| SCHEMBL26632763 | 0.73 | TNF (0.41) | CCND3CDK6CDK4CCND1TNF | |
| SCHEMBL30629504 | 0.73 | TNF (0.41) | CCND3CDK6CDK4CCND1TNF | |
| SCHEMBL24619122 | 0.72 | CDK4 (0.31) | CCND3CDK6CDK4CCND1TNF | |
| SCHEMBL21522723 | 0.72 | CDK4 (0.61) | CCND3CDK6CDK4CCND1 | |
| SCHEMBL21522760 | 0.72 | CDK4 (0.61) | CCND3CDK6CDK4CCND1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4562000-A1 | AMINOHETEROARYL KINASE INHIBITORS | Allorion Therapeutics Inc (US) | 2025-06-04 | — | — | EP | disclosed |
| CN-119630652-A | Amino heteroaryl kinase inhibitors | 安锐生物医药公司 | 2025-03-14 | — | — | CN | disclosed |
| WO-2024022487-A1 | AMINOHETEROARYL KINASE INHIBITORS | Allorion Therapeutics Inc (US) | 2024-02-01 | — | — | WO | disclosed |